Center for Patient Safety Research and Practice David Bates, MD, MSc Center Director Overview Background Accomplishments to date Before the Center Of the Center itself Other related Future vision Safety and Systems “Safety is a systems property.” Chasm Report “Every system is perfectly designed to achieve exactly the results it gets.” Donald Berwick National Developments CMS announced plan 4/14 to stop paying for Serious Reportable Adverse Events (“never” events)—n=28 FDA has announced plans to develop “Sentinel Network” Agency for Healthcare Research and Quality devoting few resources to safety research (main recent focus HIT) BWH As A Leader: Inpatient Prevention—Computerized Physician Order Entry 55% reduction in serious medication error rate with CPOE Bates, JAMA, 1998 83% reduction in overall medication error rate Bates, JAMIA, 2000 NEPHROS study Effect of real-time decision support for patients with renal insufficiency Of 17,828 patients, 42% had some degree of renal insufficiency Interv Control Dose 67% 54% Frequency 59% 35% Length of stay 0.5 days shorter Chertow et al, JAMA 2001 Medication Systems Then and Now THEN NOW BCMA Slide Courtesy of Anne Bane, RN, MSN. Brigham and Women’s Hospital Medication Location Real Time Alerts to Nurse Slide Courtesy of Anne Bane, RN, MSN, Brigham and Women’s Hospital Dispensing Errors and Potential ADEs: Before and After Barcode Technology Implementation 1.00% 0.80% 0.61% 0.60% Before Period (115164 doses observed) After Period (253984 doses observed) 0.88% 31% reduction* 63% reduction* 0.40% 0.20% 0.00% Dispensing Error Rate * p<0.0001 (Chi-squared test) Projections for errors prevented per year at study hospital: 0.19% >13,500 medication 0.07% dispensing errors >6,000 potential ADEs Potential ADE Rate Poon, Ann Intern Med, 2006 Formal Cost Benefit Analysis Results 5-year cumulative costs = $2.3M $1.4M one-time investment (pre golive, first 2 years) $343K/yr recurring (post go-live, last 3 years) 5-year cumulative benefits = $5.5M 5-year cumulative net benefit = $3.3M Break-even within 1st year after go-live Maviglia, Arch Int Med 2007 Improving the Response to Critical Labs Baseline revealed that a third not treated for 5 hours Mean time to treatment11% shorter Mean time to resolution 29% shorter Mortality was 7% in intervention group, 13% control group (p=0.19) 95% physicians pleased to be paged Kuperman, JAMIA 2000 Coverage-Related Events Before data showed patients being crosscovered at 5-fold excess risk of adverse event After computerized signout introduction, no excess risk Included medications Simple from informatics perspective but major benefit Petersen, Jt Comm Jl Take-Away Messages of Smart Pump Controlled Trial Serious IV med errors were frequent and could be detected using smart pumps However, no impact on the serious med error or preventable ADE rate was found Likely because of poor design and also compliance Behavioral and technologic factors must be addressed if smart pumps are to achieve their potential for improving medication safety Rothschild et al, Crit Care Med 2005 Reporting and Surveillance Tool Ambulatory Pediatric Epidemiology Study Improving Safety in Nursing Homes Safe Intravenous Infusion Systems Inpatient Psychiatric Epidemiology Study Organizational culture in promoting patient safety Dissemination Efforts (I) Newsletter Website: www.coesafety.bwh.harvard.edu Presentation of findings at national meetings SGIM, AMIA, NPSF, NICHQ, SCCM, Annual AHRQ Patient Safety Conference Harvard CME Course on Patient Safety ITV Patient Safety Special Dissemination Efforts (II) AHRQ Webcast Dr. Bates, Gurwitz served on recent IOM Committee WHO Dr. Leape led drafting of WHO Guidelines for Adverse Event Reporting and Learning systems Dr. Bates leading development of global agenda for patient safety research HIT-CERT Studies Automated telephone surveillance in outpatients prescribed specific medications to determine whether or not they are experiencing specific ADEs Evaluation of the impact of clinical decision support and automated telephone outreach on antihypertensive and lipid-lowering therapy Characterization of new errors with ambulatory electronic prescribing Post-discharge ambulatory medication reconciliation Evaluation of multiple vendor-based electronic prescribing systems and health information exchange on outpatient medication safety in Mass and New York Identification with AMIA of a set of clinical decision support rules that can be used in multiple settings Other Grants Study beginning supported by Pfizer to study automation of ambulatory adverse drug event reporting Study of safety climate in nursing homes underway Closing the loop on missed and delayed diagnoses Support to study role of pharmacists in the ED Study of the impact on safety of a chemotherapy robot Study of impact of attending fatigue on error rates Study funded by Aetna looking at personalizing breast cancer care based on genomic data Funding from WHO to assess global burden of patient safety Massachusetts eHealth Collaborative Effort to get all providers in state to use electronic records Have given EHRs and set up clinical data exchange in 3 communities Evaluating impact on quality, safety, and efficiency A potential model for rest of U.S. Areas of Particular Interest Medication safety Surgical safety Nosocomial infections Improving monitoring Of patients Of devices Diagnostic error Using technology effectively Safety culture/organizational interests Vision for Center BWH has long been leader in this area Multi-institutional, multi-disciplinary program Goal to bring together the best in this area Provide core support, foster collaboration Already have many investigators working in parallel Longitudinal focus is essential—problem is not going to go away